RU2019104870A - Комбинированный тест на наличие колоректального рака - Google Patents
Комбинированный тест на наличие колоректального рака Download PDFInfo
- Publication number
- RU2019104870A RU2019104870A RU2019104870A RU2019104870A RU2019104870A RU 2019104870 A RU2019104870 A RU 2019104870A RU 2019104870 A RU2019104870 A RU 2019104870A RU 2019104870 A RU2019104870 A RU 2019104870A RU 2019104870 A RU2019104870 A RU 2019104870A
- Authority
- RU
- Russia
- Prior art keywords
- patient
- cell
- colorectal cancer
- free nucleosome
- detecting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G01N33/57535—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G01N33/57585—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Claims (11)
1. Способ обнаружения и/или скрининга колоректального рака (CRC), колоректальной аденомы или полипа у пациента, включающий:
(a) идентификацию пациента, имевшего положительный результат анализа фекалий на скрытую кровь; и
(b) обнаружение или измерение уровня одного или более элементов в образце крови, сыворотки или плазмы, полученном у пациента, при этом элемент выбирают из бесклеточной нуклеосомы, эпигенетического признака бесклеточной нуклеосомы, карциноэмбрионального антигена, биомаркера метаболизма железа или индуцируемого гипоксией фактора,
при этом результат, полученный на этапе (b), указывает на вероятность наличия у пациента колоректального рака (CRC), колоректальной аденомы или полипа.
2. Способ оценки пригодности пациента для колоноскопии, включающий:
(a) анализ фекалий на скрытую кровь для образца фекалий, полученного у пациента;
(b) обнаружение или измерение уровня одного или более элементов в образце крови, сыворотки или плазмы, полученном у пациента, при этом элемент выбирают из бесклеточной нуклеосомы, эпигенетического признака бесклеточной нуклеосомы, карциноэмбрионального антигена, биомаркера метаболизма железа или индуцируемого гипоксией фактора; и
(c) использование результата, полученного в (b), в качестве показателя пригодности пациента для колоноскопии.
3. Способ по любому из пп. 1 и 2, который дополнительно включает в себя использование численного результата анализа фекалий на скрытую кровь в качестве параметра на этапе (b).
4. Способ по любому из пп. 1-3, который дополнительно включает использование клинического параметра на этапе (b).
5. Способ по п. 4, в котором клинический параметр выбирают из возраста, пола и индекса массы тела (ИМТ).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1612815.9 | 2016-07-25 | ||
| GBGB1612815.9A GB201612815D0 (en) | 2016-07-25 | 2016-07-25 | Novel combination test |
| PCT/EP2017/068754 WO2018019827A1 (en) | 2016-07-25 | 2017-07-25 | Combination test for colorectal cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2019104870A true RU2019104870A (ru) | 2020-08-25 |
| RU2019104870A3 RU2019104870A3 (ru) | 2020-12-01 |
Family
ID=56894403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019104870A RU2019104870A (ru) | 2016-07-25 | 2017-07-25 | Комбинированный тест на наличие колоректального рака |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20200182875A1 (ru) |
| EP (1) | EP3488238B1 (ru) |
| JP (1) | JP6983221B2 (ru) |
| KR (1) | KR102442803B1 (ru) |
| CN (1) | CN109791154A (ru) |
| AU (1) | AU2017301970B2 (ru) |
| BR (1) | BR112019001384A2 (ru) |
| CA (1) | CA3031580A1 (ru) |
| GB (1) | GB201612815D0 (ru) |
| IL (1) | IL264359B2 (ru) |
| MY (1) | MY193895A (ru) |
| RU (1) | RU2019104870A (ru) |
| SG (2) | SG11201900329XA (ru) |
| TW (1) | TWI776816B (ru) |
| WO (1) | WO2018019827A1 (ru) |
| ZA (1) | ZA201808601B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201906199D0 (en) * | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| WO2021024009A1 (en) * | 2019-08-02 | 2021-02-11 | Shanghai Yunxiang Medical Technology Co., Ltd. | Methods and compositions for providing colon cancer assessment using protein biomarkers |
| CN112345766B (zh) * | 2020-10-22 | 2024-02-02 | 中国工程物理研究院核物理与化学研究所 | 一种荧光-放射性联用的体外靶向筛选方法 |
| TW202242146A (zh) * | 2021-01-13 | 2022-11-01 | 比利時商比利時意志有限公司 | 肺癌的檢測方法 |
| US20240118282A1 (en) * | 2021-02-11 | 2024-04-11 | Herbert A. Fritsche | Kits and methods for detecting markers and determining the presence or risk of cancer |
| WO2024223947A1 (en) * | 2023-04-28 | 2024-10-31 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers of carcinomas |
| CN116973572B (zh) * | 2023-06-02 | 2025-03-07 | 东南大学附属中大医院 | 基于血、粪便铁蛋白检测评估肠屏障损伤严重程度的方法 |
| CN116718775B (zh) * | 2023-08-04 | 2023-10-27 | 天津迈基生物科技有限公司 | 一种检测结直肠癌的组合物、试纸及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010089538A2 (en) * | 2009-02-03 | 2010-08-12 | Oncomethylome Sciences Sa | Methods of detecting colorectal cancer |
| CN102460173A (zh) * | 2009-04-14 | 2012-05-16 | 加利福尼亚大学董事会 | 组蛋白修饰用于癌症的临床诊断和预后 |
| US8568984B2 (en) * | 2010-02-19 | 2013-10-29 | Philadelphia Health & Education Corporation | Methods of diagnosing non-urinary tract diseases by detecting aberrant methylation |
| JP2012018119A (ja) * | 2010-07-09 | 2012-01-26 | Toray Ind Inc | 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法 |
| KR20140016230A (ko) * | 2010-08-04 | 2014-02-07 | 시즐 바이오테크놀로지 리미티드 | 암의 진단 및 치료를 위한 방법 및 화합물 |
| GB201115098D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| HUE035855T2 (en) * | 2011-12-07 | 2018-05-28 | Belgian Volition Sprl | Method for detecting nucleosome adducts |
| CN104411835B (zh) * | 2012-05-11 | 2019-12-20 | 临床基因组学股份有限公司 | 用于结直肠癌的诊断性基因标记系列 |
-
2016
- 2016-07-25 GB GBGB1612815.9A patent/GB201612815D0/en not_active Ceased
-
2017
- 2017-07-25 BR BR112019001384-9A patent/BR112019001384A2/pt not_active Application Discontinuation
- 2017-07-25 RU RU2019104870A patent/RU2019104870A/ru unknown
- 2017-07-25 KR KR1020197002048A patent/KR102442803B1/ko active Active
- 2017-07-25 IL IL264359A patent/IL264359B2/en unknown
- 2017-07-25 US US16/320,440 patent/US20200182875A1/en not_active Abandoned
- 2017-07-25 SG SG11201900329XA patent/SG11201900329XA/en unknown
- 2017-07-25 CA CA3031580A patent/CA3031580A1/en active Pending
- 2017-07-25 WO PCT/EP2017/068754 patent/WO2018019827A1/en not_active Ceased
- 2017-07-25 AU AU2017301970A patent/AU2017301970B2/en not_active Ceased
- 2017-07-25 EP EP17743043.6A patent/EP3488238B1/en active Active
- 2017-07-25 MY MYPI2019000398A patent/MY193895A/en unknown
- 2017-07-25 CN CN201780045694.2A patent/CN109791154A/zh active Pending
- 2017-07-25 JP JP2019503672A patent/JP6983221B2/ja active Active
- 2017-07-25 TW TW106124811A patent/TWI776816B/zh active
- 2017-07-25 SG SG10202100630SA patent/SG10202100630SA/en unknown
-
2018
- 2018-12-20 ZA ZA2018/08601A patent/ZA201808601B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019527361A (ja) | 2019-09-26 |
| EP3488238C0 (en) | 2023-06-07 |
| AU2017301970A1 (en) | 2019-01-17 |
| BR112019001384A2 (pt) | 2019-04-30 |
| SG10202100630SA (en) | 2021-03-30 |
| AU2017301970B2 (en) | 2023-04-27 |
| IL264359A (en) | 2019-02-28 |
| WO2018019827A1 (en) | 2018-02-01 |
| IL264359B2 (en) | 2024-03-01 |
| EP3488238B1 (en) | 2023-06-07 |
| IL264359B1 (en) | 2023-11-01 |
| CA3031580A1 (en) | 2018-02-01 |
| EP3488238A1 (en) | 2019-05-29 |
| CN109791154A (zh) | 2019-05-21 |
| MY193895A (en) | 2022-10-31 |
| KR102442803B1 (ko) | 2022-09-15 |
| SG11201900329XA (en) | 2019-02-27 |
| TWI776816B (zh) | 2022-09-11 |
| JP6983221B2 (ja) | 2021-12-17 |
| ZA201808601B (en) | 2019-09-25 |
| RU2019104870A3 (ru) | 2020-12-01 |
| US20200182875A1 (en) | 2020-06-11 |
| GB201612815D0 (en) | 2016-09-07 |
| KR20190039089A (ko) | 2019-04-10 |
| TW201804156A (zh) | 2018-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019104870A (ru) | Комбинированный тест на наличие колоректального рака | |
| Bahadır et al. | Applications of electrochemical immunosensors for early clinical diagnostics | |
| Kaczor‐Urbanowicz et al. | Emerging technologies for salivaomics in cancer detection | |
| Bakirhan et al. | Recent progress on the sensitive detection of cardiovascular disease markers by electrochemical-based biosensors | |
| Qi et al. | Circulating long non-coding RNAs in cancer: current status and future perspectives | |
| Farzin et al. | Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies | |
| Lee et al. | Aptamer-based sandwich assay and its clinical outlooks for detecting lipocalin-2 in hepatocellular carcinoma (HCC) | |
| Zhao et al. | Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma | |
| JP2008542703A5 (ru) | ||
| US20180080937A1 (en) | Biomarker Panel For Diagnosing Cancer | |
| RU2014112350A (ru) | Способ детекции нуклеосом, содержащих нуклеотиды | |
| JP2018504609A5 (ru) | ||
| JP2019527361A5 (ru) | ||
| Roe et al. | Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case–control study | |
| JP2016500110A5 (ru) | ||
| Beretov et al. | Proteomics for breast cancer urine biomarkers | |
| JP2011526693A5 (ru) | ||
| Pardi et al. | Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers? | |
| JP2009538607A5 (ru) | ||
| Kammer et al. | Noninvasive biomarkers for lung cancer diagnosis, where do we stand? | |
| Bilegsaikhan et al. | Circulating miR‐338‐5p is a potential diagnostic biomarker in colorectal cancer | |
| Werner et al. | Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer | |
| JP2011508197A5 (ru) | ||
| WO2015100459A3 (en) | Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies | |
| JP2018529931A5 (ru) |